⚠️ Fair warning: this is the biggest one yet. Get comfortable — grab your coffee, maybe a notebook. This is the conversation I have almost every single Saturday at the market, and it deserves the full story.

THE HORMONE CONVERSATION NOBODY HAD WITH YOU

How One Flawed Study Convinced a Generation of Women to Suffer in Silence — and What the Science Actually Says Now

Important note: This post is for educational and informational purposes only. Nothing here constitutes medical advice, and nothing here is a recommendation for you personally to start, stop, or change any medication or hormone therapy. Please consult a qualified healthcare provider — ideally one with real menopause training — before making any decisions about hormone therapy. Julie is a holistic nutritionist sharing her research and perspective, not your doctor.

Almost every Saturday, someone finds their way to my table not for a soap bar, but for this conversation. She's 44, or 51, or 58. She's not sleeping. She's gaining weight in places she never used to. Her joints ache. She cries at commercials. Her doctor told her it's just stress, or just aging, or suggested an antidepressant and sent her on her way. And almost always, somewhere in the conversation, she says some version of: "I looked into hormones once, but I heard they cause cancer."

I want to spend this entire post on where that fear came from, why it was built on a foundation that doesn't hold up, and what the actual current research says. This is, without exaggeration, one of the biggest medical misunderstandings of the last thirty years — and it has caused real, measurable harm.

THE STUDY THAT CHANGED EVERYTHING: WHAT THE WHI ACTUALLY WAS

In 2002, the Women's Health Initiative (WHI) — a massive, well-funded, and well-intentioned study — released early results from its hormone therapy trial. The headline that reached the public was blunt: hormone replacement therapy increases your risk of breast cancer and heart disease. Newspapers ran with it. Doctors panicked. Within a year of that announcement, hormone therapy use among postmenopausal women in the U.S. dropped by nearly half, and it stayed suppressed for the next two decades. An entire generation of women were pulled off hormone therapy or never offered it in the first place, largely on the strength of this one study.

Here's what most people were never told: the WHI had serious design flaws, and researchers have spent the twenty-plus years since picking them apart.

The age problem. The average age of women enrolled in the WHI was 63 — a full decade or more past the average age of menopause onset (around 51-52). Many participants were 10, 15, even 20 years past menopause when they started hormone therapy for the first time in the study. That's not a small detail. Starting hormone therapy for the first time many years after menopause, in women who may already have underlying arterial plaque or subclinical cardiovascular disease, is a fundamentally different scenario than starting it during the menopause transition itself, when the arterial lining is still healthy. Critics pointed this out almost immediately, and the WHI's own investigators never adequately addressed it.

The hormone problem. The WHI used one specific formulation: oral conjugated equine estrogen (derived from pregnant horse urine) combined with a synthetic progestin called medroxyprogesterone acetate, taken continuously. This is not the same as bioidentical estrogen and progesterone, and it's not the only way to dose or deliver hormone therapy. The WHI's own writing group stated at the time that their results shouldn't be extrapolated to other formulations or doses — a caveat that got lost entirely in the media coverage.

The breast cancer finding, more carefully read. This is the part that surprises people most: the WHI's estrogen-only arm (used in women who'd had a hysterectomy) actually showed a decreased risk of breast cancer. It was only the estrogen-plus-synthetic-progestin arm that showed a small increased risk — and even there, there was no increased risk of breast cancer mortality. The absolute risk increase was small enough that, reported honestly, it likely wouldn't have triggered the mass exodus from hormone therapy that followed. It was reported as a relative risk increase, which sounds far more alarming than the actual absolute numbers ever supported.

The result of all this: a flawed, narrow, misreported study set women's health back by decades. Doctors stopped prescribing. Medical schools stopped teaching it. An entire generation of physicians — the ones treating you right now — came through training during the decades when hormone therapy was treated as something to avoid, not something to understand.

WHAT WE KNOW NOW: THE TIMING HYPOTHESIS

In the years since, researchers have gone back through the data by age group, and additional trials — including the Kronos Early Estrogen Prevention Study (KEEPS) and the Early versus Late Intervention Trial (ELITE) — have specifically tested what happens when hormone therapy starts earlier.

The pattern that's emerged is now called the timing hypothesis (also called the "critical window"): the benefits and risks of hormone therapy depend heavily on when you start, relative to menopause. Women who start hormone therapy before age 60, or within 10 years of their final period, tend to see real cardiovascular benefit, bone protection, and symptom relief, with a favorable safety profile. Women who start it many years later — the exact scenario the WHI was largely testing — don't see the same benefit, and may see more risk. This single distinction largely explains why the WHI found what it found, and why so much research since has told a different story.

Major medical bodies have caught up to this. The Menopause Society's current position statement supports hormone therapy as the most effective treatment available for menopause symptoms in appropriate candidates, particularly when started within that window.

LET'S DEFINE OUR TERMS: MENOPAUSE IS ONE DAY

Here's something that surprises almost everyone: menopause is not a years-long experience. It's a single point in time — retroactively defined as the day that marks 12 full months since your last period. That's it. Everything before that point — the irregular cycles, the hot flashes, the mood swings, the sleep issues, all of it — is technically perimenopause, the transition leading up to that one-day marker. Perimenopause can last anywhere from a few years to closer to a decade.

I say this not to be pedantic, but because it matters for the conversation with your doctor. When most of us say "I think I'm going through menopause," what we usually mean is "I'm in perimenopause" — and that transition, not the single-day marker at the end of it, is where the bulk of symptoms and the bulk of the decision-making around hormone therapy actually happens.

THE SYMPTOMS: WHAT LOSING EACH HORMONE ACTUALLY FEELS LIKE

Perimenopause isn't a single hormone declining on a clean, predictable schedule. Estrogen, progesterone, and testosterone all decline — but at different rates, at different times, and with different symptom profiles.

Symptoms of declining estrogen: Hot flashes and night sweats, vaginal dryness, painful sex, recurrent UTIs, sleep disruption, mood changes and increased anxiety, brain fog and memory lapses, joint aches, dry skin and hair, loss of skin elasticity, irregular or heavy periods, headaches or migraines, and declining bone density.

Symptoms of declining progesterone (often the first hormone to noticeably drop, sometimes years before estrogen falls significantly): Difficulty falling or staying asleep, increased anxiety and a "wired but tired" feeling, heavier or more irregular periods, breast tenderness, mood swings, irritability, and reduced resilience to everyday stress.

Symptoms of declining testosterone (yes — women make and need testosterone too, just in smaller amounts than men): Low libido, persistent fatigue, loss of muscle tone and strength, brain fog, low motivation, and a flattened sense of overall well-being.

If you're reading this list feeling a little called out, you're far from alone. One large study found that among perimenopausal and menopausal women, the five most common symptoms were fatigue, memory problems, difficulty concentrating, irritability, and feeling tense or anxious — hot flashes ranked far lower on the list than most people expect. So much of the conversation focuses on hot flashes that women with the far more common cognitive and mood symptoms often don't connect the dots back to their hormones at all.

TESTING: WHY IT'S COMPLICATED (AND WHY THAT'S OKAY)

A natural next question is: can't I just get a blood test to check my levels? Sort of — but it's more complicated than it sounds.

Estrogen and progesterone fluctuate significantly, even hour to hour, let alone day to day, especially during perimenopause when your cycles are already becoming erratic. A single blood draw showing "normal" estrogen tells you almost nothing about what your levels looked like yesterday or will look like next week. This is a big part of why testing alone can be so misleading during this transition.

Testosterone is a different story — it's more stable day to day, and can be meaningfully tested and tracked over time, which is part of why testosterone therapy for women, while still less standardized in the U.S., tends to be easier to dose and monitor with lab work.

This leads to the single most important point in this whole section:

Perimenopause and menopause are clinically diagnosed conditions. Your symptoms — not a lab value — are what determine the diagnosis and guide treatment. A good menopause-literate provider will treat a thorough symptom history as the primary diagnostic tool, using labs to support the picture rather than to gatekeep it. If a doctor's entire response to your symptoms is "your labs are normal, so there's nothing wrong," that's a sign they may not be up to date on how this transition is actually diagnosed and managed.

HRT OPTIONS: WHAT'S ACTUALLY OUT THERE

If hormone therapy is a fit for you and your provider agrees, bioidentical hormone therapy comes in several delivery forms, each with real tradeoffs:

Patches — Estrogen absorbed through the skin, changed once or twice a week. Because it bypasses the liver (avoiding what's called "first-pass metabolism"), transdermal delivery carries a meaningfully lower risk of blood clots compared to oral forms, along with steadier hormone levels throughout the day. This is often considered the preferred starting point for estrogen by many menopause specialists specifically because of this safety profile.

Creams and gels — Also transdermal, same liver-bypass benefit as patches, with more flexibility to adjust dosing incrementally. Vaginal estrogen cream specifically treats local symptoms (dryness, painful sex, recurrent UTIs) with minimal systemic absorption, making it one of the lowest-risk, most under-prescribed tools in the entire menopause toolkit.

Oral (pill) forms — Convenient, but processed through the liver first, which increases production of clotting factors and can raise clotting risk more than transdermal options. Oral progesterone specifically (taken at bedtime) has research behind it for improving sleep quality, which is a genuine advantage of that particular route even given the general oral-vs-transdermal tradeoff.

Pellets — Inserted under the skin, releasing hormones steadily over a few months. Convenient in that you're not managing a daily routine, but the big drawback is that once it's in, you can't easily adjust or remove the dose if it's too high or not the right fit — you're committed until it wears off. This is my least favorite of the mainstream options for exactly that reason; hormone needs are not a "set it and forget it" situation, especially early on while you're still dialing things in.

A note on birth control pills. If you're still cycling and bring perimenopause symptoms to your doctor, there's a good chance you'll be offered a birth control pill as the first solution. It's an easy, familiar prescription for most doctors to write — but it's worth knowing what you're actually being offered: synthetic hormones, at doses often far higher than what bioidentical HRT would use, that many women don't tolerate well. Birth control pills also can't be split apart and dosed by time of day the way bioidentical hormones can — and that flexibility genuinely matters. Progesterone taken at bedtime can support sleep; testosterone in the morning can support energy. A birth control pill is one fixed dose, doing one thing, all day. It's not automatically the wrong choice, but it's also not automatically the right one just because it's the option most readily offered.

WHY SOONER IS BETTER — AND WHAT "SOONER" ACTUALLY MEANS

Given everything above about the timing hypothesis, here's the headline: starting hormone therapy earlier in the transition — generally understood as before age 60, or within about 10 years of your final period — is associated with real protective benefits for three systems that become major concerns for women as they age: the heart, the brain, and the bones.

In practice, "sooner" often means the early-to-mid 40s for many women — right when perimenopause symptoms are first becoming noticeable, well before most people think of themselves as candidates for hormone therapy at all. This is a big mental shift from the outdated idea of hormone therapy as a last resort for older women with severe hot flashes. The research increasingly supports thinking about it as a proactive, protective tool to bring into the conversation as soon as symptoms start — not something to wait on until things become unbearable.

HAVING THIS CONVERSATION WITH YOUR DOCTOR

This is, in my experience, the hardest part — harder than any of the science above.

Because of the two decades of fallout from the WHI, an enormous number of practicing physicians, including OB-GYNs, received little to no real training on menopause management. Studies have found that a large majority of OB-GYN residents report feeling uncomfortable discussing menopause with patients. That's not a knock on individual doctors — it's a real gap in medical education created directly by the fear the WHI generated. Demand from patients is rising quickly, and the medical field is slowly catching up, but you may genuinely need to advocate for yourself, sometimes more than once, sometimes with more than one provider.

A few things worth knowing as you navigate this:

Boutique menopause clinics exist and can be a great option if you have the financial means and want a highly personalized, concierge-style experience. Just know that many of these clinics lean heavily on pellet therapy, partly because it's profitable and low-effort to administer. Given the "can't adjust it once it's in" drawback mentioned above, I'd encourage real caution before that's your entry point into hormone therapy, especially before you know how your body responds to hormones at all.

Insurance and Medicaid can cover hormone therapy when billed correctly through a primary care provider or gynecologist, and for most people, this is actually the better place to start rather than an out-of-pocket boutique clinic — especially at the beginning, while you're still figuring out what you need.

This is not a "set it and forget it" treatment. Your needs will likely shift over the years as you move through perimenopause and into full menopause and beyond. Dosages get adjusted. Delivery methods sometimes change. This means the relationship with your provider matters as much as the prescription itself — you want someone who will stay in the conversation with you for years, not someone who writes one prescription and moves on.

You are the client. If a provider dismisses your symptoms, refuses to engage with current research, or makes you feel unheard, that is a completely valid reason to find someone else. There are thousands of doctors out there, and a growing number of them are genuinely well-versed in this. You are allowed to leave a provider relationship that isn't serving you, the same way you would with any other professional you're paying for a service.

HORMONES AND YOUR SKIN

This blog is, at the end of the day, about skin — so let's bring it back there. Estrogen plays a direct role in skin thickness, hydration, and collagen production. As estrogen declines through perimenopause, skin often becomes thinner, drier, less elastic, and slower to heal — on top of everything we've already covered in our Sleep Deficit post about how collagen production and breakdown are affected by rest and cortisol. Hormones and sleep are pulling on the same rope here.

On a purely personal note: I use a small amount of my prescribed vaginal estrogen cream on my facial skin as part of my regular routine, and the difference in texture and hydration has been noticeable enough that I don't skip it. I want to be careful here — this is a personal choice made in partnership with my own prescribing provider, using a product prescribed for a specific purpose, and it is absolutely not a suggestion that you self-direct a prescription medication to a new use without talking to your own doctor first. But it's a good example of how much overlap there really is between what we think of as "skincare" and what's actually a hormone conversation underneath.

RESOURCES WORTH YOUR TIME

If this post opened up more questions than it answered — good, that was the point. Here are the people and organizations I trust most on this topic, and where you can find them:

• Dr. Rachel Rubin — board-certified urologist and sexual medicine specialist, and one of the loudest, most effective advocates behind the recent removal of the FDA's black box warning on vaginal estrogen. Website: rachelrubinmd.com. YouTube: search "Dr. Rachel Rubin."
• Dr. Mary Claire Haver — board-certified OB-GYN, Menopause Society Certified Practitioner, and New York Times bestselling author of The New Menopause. Website: thepauselife.com. Podcast: The Hello Menopause / unPAUSED.
• Dr. Kelly Casperson — board-certified urologist and host of the You Are Not Broken podcast, covering hormones, sexual health, and menopause with a lot of humor and zero judgment. Website: kellycaspersonmd.com.
• The Menopause Society (formerly NAMS) — the leading independent, evidence-based professional organization on menopause. Their site includes a searchable directory of Menopause Society Certified Practitioners (MSCPs) near you. Website: menopause.org.

Start with any one of these if you're looking for a place to begin your own research, or to find language for your next doctor's appointment.

WHAT YOU PUT ON YOUR SKIN STILL MATTERS

None of this makes skincare irrelevant — it means skincare works best as part of a bigger picture that includes what's happening hormonally underneath it.

Grass-fed tallow delivers the same bioidentical fatty acid profile as human sebum, supporting the skin barrier at exactly the moment in life when declining estrogen is making that barrier thinner and less resilient. It's not a replacement for hormone therapy, and it was never meant to be. But it's a genuinely good tool to have in your corner while you're doing the harder, more important work of figuring out your hormones with a provider who actually listens to you.

You deserve to feel like yourself again. That's true for your skin, and it's true for everything else this transition touches.

"When you give women information about how their bodies work, they make great decisions for themselves." — Dr. Rachel Rubin

You are not broken. You are not too much. You are allowed to ask for better care.

— Julie Conradt, Magnolia Crow Soap Co.